This document summarizes a case presentation of a 74-year-old Thai female patient undergoing peritoneal dialysis who presented with increasing fatigue. Her peritoneal dialysis prescription was adjusted and tests revealed a left pleural effusion. Further imaging with nuclear scintigraphy confirmed omental wrapping around the peritoneal catheter. The patient was temporarily switched to hemodialysis and underwent catheter revision surgery. The importance of proper peritoneal catheter placement and design is discussed to reduce complications.
This document discusses renal replacement therapy (RRT) including the stages of kidney disease, types of dialysis, and access methods. It covers the primary functions of the kidney and consequences of kidney failure. The two main types of RRT are peritoneal dialysis and hemodialysis. Peritoneal dialysis uses the peritoneal membrane as a filter through a catheter, while hemodialysis uses an artificial kidney external to the body with vascular access.
Dr alaa saleh complications of peritoneal dialysis (2)FarragBahbah
Peritoneal dialysis complications include:
1) Catheter related issues such as pain, poor flow, and cuff erosion.
2) Hernias which occur in 10-20% of patients and are minimized by proper catheter placement.
3) Dialysate leaks which can occur through the exit site or cause hydrothorax and are related to catheter placement.
4) Metabolic complications from glucose absorption which can cause weight gain, hypertriglyceridemia, and loss of amino acids in the effluent dialysate.
This document discusses the use of peritoneal dialysis (PD) for acute kidney injury (AKI). It finds that PD is a viable option for RRT in AKI, especially in remote or resource-limited settings. Several studies have found mortality rates similar to other RRT modalities like CRRT. PD offers advantages of wider availability, lower cost, and gentler fluid removal in unstable patients. High-volume PD techniques can provide clearance comparable to intermittent hemodialysis. While concerns remain around clearance and peritonitis risk, evidence suggests PD is a valuable complementary therapy for selected AKI cases.
Nomenclature c hd,c-hfc-hdf scuf sled clinical indications - copyIrfan Elahi
This document discusses different types of renal replacement therapies including hemodialysis, hemofiltration, hemodiafiltration, SLED, SLED-F, and continuous renal replacement therapy (CRRT). It explains the differences between diffusive clearance provided by hemodialysis and convective clearance provided by hemofiltration. CRRT provides benefits over intermittent hemodialysis by allowing for more stable fluid removal and better azotemia control. Choice of therapy depends on factors like hemodynamic stability, availability of resources, and setting.
vascular access for dialysis access: seminarMd Rahman
This document discusses vascular access for hemodialysis. It describes the different types of access including fistulas, grafts, and catheters. Fistulas are the preferred type as they last longest and have lowest risk of complications. Grafts are also used but have shorter lifespan. Catheters are not ideal for permanent access but can be used immediately while other access matures. The document outlines how to place and care for each type of access. Complications of catheters include higher risk of infection due to direct bloodstream access. Proper placement of catheter tips in the superior vena cava or right atrium is also discussed.
The document summarizes potential complications of peritoneal dialysis catheters including malfunctioning catheters, early and late non-functioning, and causes such as constipation, intra-abdominal adhesions from previous surgery or peritonitis, catheter migration, blood or fibrin blocking the catheter, and hernias. It describes methods for investigating malfunctioning catheters including abdominal x-rays, x-rays with contrast dye, and CT scans. It provides guidance on managing different causes through measures like laxatives, re-siting the catheter, adding heparin to dialysate, or removing the catheter.
Arteriovenous vascular access complicationsReynel Dan
The document discusses various complications that can occur with arteriovenous vascular access for hemodialysis patients. It describes immediate post-surgery complications like hemorrhage and low venous flow. Late complications include infections, aneurysm formation, fistula vein stenosis, congestive heart failure, steal syndrome, ischemic neuropathy, and thrombosis. The document also outlines various physical findings that are associated with different forms of access dysfunction.
This document discusses renal replacement therapy (RRT) including the stages of kidney disease, types of dialysis, and access methods. It covers the primary functions of the kidney and consequences of kidney failure. The two main types of RRT are peritoneal dialysis and hemodialysis. Peritoneal dialysis uses the peritoneal membrane as a filter through a catheter, while hemodialysis uses an artificial kidney external to the body with vascular access.
Dr alaa saleh complications of peritoneal dialysis (2)FarragBahbah
Peritoneal dialysis complications include:
1) Catheter related issues such as pain, poor flow, and cuff erosion.
2) Hernias which occur in 10-20% of patients and are minimized by proper catheter placement.
3) Dialysate leaks which can occur through the exit site or cause hydrothorax and are related to catheter placement.
4) Metabolic complications from glucose absorption which can cause weight gain, hypertriglyceridemia, and loss of amino acids in the effluent dialysate.
This document discusses the use of peritoneal dialysis (PD) for acute kidney injury (AKI). It finds that PD is a viable option for RRT in AKI, especially in remote or resource-limited settings. Several studies have found mortality rates similar to other RRT modalities like CRRT. PD offers advantages of wider availability, lower cost, and gentler fluid removal in unstable patients. High-volume PD techniques can provide clearance comparable to intermittent hemodialysis. While concerns remain around clearance and peritonitis risk, evidence suggests PD is a valuable complementary therapy for selected AKI cases.
Nomenclature c hd,c-hfc-hdf scuf sled clinical indications - copyIrfan Elahi
This document discusses different types of renal replacement therapies including hemodialysis, hemofiltration, hemodiafiltration, SLED, SLED-F, and continuous renal replacement therapy (CRRT). It explains the differences between diffusive clearance provided by hemodialysis and convective clearance provided by hemofiltration. CRRT provides benefits over intermittent hemodialysis by allowing for more stable fluid removal and better azotemia control. Choice of therapy depends on factors like hemodynamic stability, availability of resources, and setting.
vascular access for dialysis access: seminarMd Rahman
This document discusses vascular access for hemodialysis. It describes the different types of access including fistulas, grafts, and catheters. Fistulas are the preferred type as they last longest and have lowest risk of complications. Grafts are also used but have shorter lifespan. Catheters are not ideal for permanent access but can be used immediately while other access matures. The document outlines how to place and care for each type of access. Complications of catheters include higher risk of infection due to direct bloodstream access. Proper placement of catheter tips in the superior vena cava or right atrium is also discussed.
The document summarizes potential complications of peritoneal dialysis catheters including malfunctioning catheters, early and late non-functioning, and causes such as constipation, intra-abdominal adhesions from previous surgery or peritonitis, catheter migration, blood or fibrin blocking the catheter, and hernias. It describes methods for investigating malfunctioning catheters including abdominal x-rays, x-rays with contrast dye, and CT scans. It provides guidance on managing different causes through measures like laxatives, re-siting the catheter, adding heparin to dialysate, or removing the catheter.
Arteriovenous vascular access complicationsReynel Dan
The document discusses various complications that can occur with arteriovenous vascular access for hemodialysis patients. It describes immediate post-surgery complications like hemorrhage and low venous flow. Late complications include infections, aneurysm formation, fistula vein stenosis, congestive heart failure, steal syndrome, ischemic neuropathy, and thrombosis. The document also outlines various physical findings that are associated with different forms of access dysfunction.
Post-obstructive diuresis refers to high urine output that can occur after relief of urinary tract obstruction. It is caused by accumulation of water, sodium, and urea during the period of obstruction. There are two main types - physiological diuresis which is self-limiting as fluid balance returns to normal, and pathological diuresis where inappropriate water loss continues beyond normalization of volume status. Treatment involves careful fluid management to replace losses based on urine output and electrolyte monitoring, as most cases will resolve spontaneously once homeostasis is restored. However, those with risk factors like edema may require closer monitoring and intravenous fluids.
The patient is a 49-year-old woman with end-stage renal disease and diabetes who presented with altered mental status. She receives hemodialysis three times per week for a few years. Recently, she has been increasingly tired, weak, and unable to perform daily activities with poor appetite and nausea. On examination, she was pale and swollen with low hemoglobin. Tests found elevated creatinine, BUN, and electrolyte abnormalities. The most probable diagnosis is inadequate hemodialysis, as her symptoms and labs are consistent with worsening uremia due to insufficient solute clearance from her dialysis sessions. Kt/V is a measure of dialysis adequacy that accounts for urea clearance and patient
Brief pathway to handle temporary HD catheterMNDU net
This document provides guidance on the use of temporary hemodialysis catheters. It discusses indications for temporary catheters such as acute kidney injury or as a bridge to renal transplantation. Types of temporary catheters and precautions before insertion are outlined. The document also reviews care after insertion, common complications, and how to manage catheter-related bloodstream infections. The overall message is that arteriovenous fistula is preferred for end-stage renal disease patients requiring long-term hemodialysis, but temporary catheters have a role when fistula is not ready or in cases of acute kidney injury.
This document provides an overview of anticoagulation options for hemodialysis. It discusses conventional anticoagulants like unfractionated heparin and low molecular weight heparins. It also covers newer direct thrombin inhibitors and regional anticoagulation methods using citrate or prostacyclin. The risks and benefits of each option are evaluated based on bleeding risks, reversibility, cost, and ability to prevent clotting during hemodialysis procedures. Monitoring requirements and dosing protocols are also reviewed for different anticoagulant regimens.
CRRT describes a group of renal replacement therapies that provide continuous renal replacement over an extended period of time, typically 24 hours per day. There are several CRRT modalities including CVVH, CVVHD, and CVVHDF that utilize different molecular transport mechanisms like diffusion, convection, and ultrafiltration. CRRT is commonly used to treat acute kidney injury as it closely mimics the native kidney and is better tolerated by hemodynamically unstable patients. Studies have shown that earlier initiation of CRRT and achieving an adequate dose of effluent flow rate or solute clearance may improve survival rates in patients with acute renal failure.
CRRT (continuous renal replacement therapy) involves using an extracorporeal circuit connected to the patient via catheters to slowly remove fluid and toxins over 24 hours, mimicking the function of the kidneys. It was developed for critically ill patients who cannot tolerate the fluid shifts of intermittent hemodialysis. CRRT uses a semipermeable membrane to filter fluids and small molecules from the blood based on hydrostatic pressure gradients. It provides more hemodynamic stability than intermittent hemodialysis and allows for better nutrition support by preventing fluid overload. CRRT is indicated for patients who cannot tolerate intermittent dialysis due to hemodynamic instability from their critical illness.
This document provides information on inserting tunneled dialysis catheters. It discusses the preferred insertion sites being the right internal jugular vein. Potential acute complications during insertion include arterial puncture, pneumothorax, hemothorax, and air embolism. Subacute complications after insertion include suboptimal flow due to malposition, kinking, clots or fibrin sheath formation. Tunnel tract infection is also discussed as a complication requiring antibiotic treatment and catheter removal. The document provides guidance on preventing and managing these potential complications.
- Short-term catheters should only be used for acute dialysis or limited hospital use. Non-cuffed femoral catheters are only for bed-bound patients.
- Long-term catheters should be used with a plan for permanent access and prefer those capable of high flow rates. Choice depends on local experience and goals.
- Long-term catheters should avoid the same side as a maturing arteriovenous access, if possible.
This document discusses the management of pregnant women on hemodialysis. It notes that physiological changes during pregnancy can impact kidney function, but intensive hemodialysis of more than 20 hours per week is recommended to reduce risks. Close monitoring of blood pressure, nutrition, mineral levels, anemia and fetal growth is important. Hemodialysis prescription should be tailored to each patient's needs, with adjustments to dialysate composition and blood flow. Vaginal delivery at 38 weeks is typically recommended unless complications arise. A multidisciplinary team of nephrologists, obstetricians and dietitians helps optimize outcomes for these high-risk pregnancies.
This document discusses evaluating the adequacy of hemodialysis treatment. It states that numerous studies have shown a correlation between the delivered dose of hemodialysis and patient mortality and morbidity. The urea reduction ratio (URR), which measures the percentage reduction of urea levels pre- and post-dialysis, is one way to evaluate adequacy, with a URR over 60% generally associated with better outcomes. Equilibrated Kt/V is also discussed as a standard measure of dialysis dose, with a minimum of 1.4 recommended. The document outlines factors that influence adequacy, including treatment time and frequency, dialyzer characteristics, blood and dialysate flow rates, and dialysis solution composition
Although large efforts are spent for creating fistula as the primary access, use of Hemodialysis Vascular catheters are still the major access on the first Hemodialysis session and after 4 month whether we would like it or not.
"USRDS 2013"
A very simple yet comprehensive presentation to understand the concept of CRRT and its implementation in Intensive Care Unit. Intended for the very beginners in ICU. After going through the presentation you will be able to say "Now I know it!"
This document discusses guidelines for prescribing hemodialysis for acute kidney injury patients. It covers key elements of the prescription including session length and blood flow rate, dialyzer selection, dialysate composition, and ultrafiltration orders. The presentation emphasizes starting more frequent but shorter sessions at lower intensity initially and gradually increasing session length and clearance as the patient stabilizes to prevent dialysis disequilibrium syndrome.
The document discusses the history and development of hemodialysis adequacy measures. It describes how Frank Gotch and John Sargent developed the Kt/V measure in the 1970s to more accurately assess dialysis dose based on urea clearance. This resolved issues with prior methods that used target BUN levels. The document outlines the benefits of Kt/V over BUN and notes minimum recommended levels of Kt/V and URR to ensure adequate dialysis.
Renal replacement therapies like dialysis and continuous renal replacement therapies are used to replace kidney function in patients with kidney failure. Dialysis involves diffusion of toxins out of the bloodstream across a semipermeable membrane. The main types of dialysis are hemodialysis, which uses an external dialysis machine, and peritoneal dialysis, which uses the patient's peritoneum. Hemodialysis requires vascular access via an arteriovenous fistula or graft and occurs several times per week. Peritoneal dialysis involves infusing dialysate into the peritoneal cavity daily to remove waste through the peritoneum. Continuous renal replacement therapies continuously filter blood using convection and diffusion.
The document discusses complications of peritoneal dialysis, specifically peritonitis. It describes the typical presentation of peritonitis as abdominal pain and cloudy dialysate fluid. Causes include breaks in sterile technique or recent infections. Diagnosis requires abdominal pain and cloudy fluid with leukocytosis. Treatment involves empiric antibiotics targeting gram positive and negative organisms. Outcomes depend on causative organisms and whether the peritoneal catheter is infected.
This document discusses principles of hemodialysis including definitions, concepts of clearance, and factors that affect diffusion and ultrafiltration during the hemodialysis process. It describes how solutes and water move across the semipermeable dialysis membrane through diffusion, osmosis, and ultrafiltration. Key factors that determine solute removal rates and ultrafiltration volumes are membrane type, blood and dialysate flow rates, and transmembrane pressure. The document also compares diffusive and convective solute removal and discusses how countercurrent dialysate flow optimizes solute clearance.
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfAyman Seddik
1. The document discusses guidelines for the prevention and management of peritonitis from the ISPD 2022 updates. It focuses on key areas such as the standardized definitions of peritonitis, measurement of peritonitis rates, prevention strategies like exit site care and antibiotic prophylaxis, and treatment recommendations.
2. The new guidelines recommend monitoring peritonitis rates and aiming for a rate of less than 0.4 episodes per patient year. Prevention strategies discussed include proper exit site care, antibiotic prophylaxis before catheter placement and invasive procedures, and patient education.
3. Treatment guidelines cover initial antibiotic therapy based on peritonitis type and symptoms, and monitoring response and indications for catheter removal. Overall the document summar
This document provides an overview of chronic kidney failure (CKF), including its definition, classification, incidence, etiology, clinical presentation, investigations, management, complications, and references. Some key points include:
CKF is a progressive decrease in renal function over 3 months or more, leading to accumulation of waste and electrolyte abnormalities. Diabetes and hypertension are the leading causes of CKF. Treatment options for CKF include dialysis, renal transplant, or conservative management. Dialysis can be done through hemodialysis or peritoneal dialysis. Renal transplant provides the best outcomes for patients compared to long-term dialysis.
Post-obstructive diuresis refers to high urine output that can occur after relief of urinary tract obstruction. It is caused by accumulation of water, sodium, and urea during the period of obstruction. There are two main types - physiological diuresis which is self-limiting as fluid balance returns to normal, and pathological diuresis where inappropriate water loss continues beyond normalization of volume status. Treatment involves careful fluid management to replace losses based on urine output and electrolyte monitoring, as most cases will resolve spontaneously once homeostasis is restored. However, those with risk factors like edema may require closer monitoring and intravenous fluids.
The patient is a 49-year-old woman with end-stage renal disease and diabetes who presented with altered mental status. She receives hemodialysis three times per week for a few years. Recently, she has been increasingly tired, weak, and unable to perform daily activities with poor appetite and nausea. On examination, she was pale and swollen with low hemoglobin. Tests found elevated creatinine, BUN, and electrolyte abnormalities. The most probable diagnosis is inadequate hemodialysis, as her symptoms and labs are consistent with worsening uremia due to insufficient solute clearance from her dialysis sessions. Kt/V is a measure of dialysis adequacy that accounts for urea clearance and patient
Brief pathway to handle temporary HD catheterMNDU net
This document provides guidance on the use of temporary hemodialysis catheters. It discusses indications for temporary catheters such as acute kidney injury or as a bridge to renal transplantation. Types of temporary catheters and precautions before insertion are outlined. The document also reviews care after insertion, common complications, and how to manage catheter-related bloodstream infections. The overall message is that arteriovenous fistula is preferred for end-stage renal disease patients requiring long-term hemodialysis, but temporary catheters have a role when fistula is not ready or in cases of acute kidney injury.
This document provides an overview of anticoagulation options for hemodialysis. It discusses conventional anticoagulants like unfractionated heparin and low molecular weight heparins. It also covers newer direct thrombin inhibitors and regional anticoagulation methods using citrate or prostacyclin. The risks and benefits of each option are evaluated based on bleeding risks, reversibility, cost, and ability to prevent clotting during hemodialysis procedures. Monitoring requirements and dosing protocols are also reviewed for different anticoagulant regimens.
CRRT describes a group of renal replacement therapies that provide continuous renal replacement over an extended period of time, typically 24 hours per day. There are several CRRT modalities including CVVH, CVVHD, and CVVHDF that utilize different molecular transport mechanisms like diffusion, convection, and ultrafiltration. CRRT is commonly used to treat acute kidney injury as it closely mimics the native kidney and is better tolerated by hemodynamically unstable patients. Studies have shown that earlier initiation of CRRT and achieving an adequate dose of effluent flow rate or solute clearance may improve survival rates in patients with acute renal failure.
CRRT (continuous renal replacement therapy) involves using an extracorporeal circuit connected to the patient via catheters to slowly remove fluid and toxins over 24 hours, mimicking the function of the kidneys. It was developed for critically ill patients who cannot tolerate the fluid shifts of intermittent hemodialysis. CRRT uses a semipermeable membrane to filter fluids and small molecules from the blood based on hydrostatic pressure gradients. It provides more hemodynamic stability than intermittent hemodialysis and allows for better nutrition support by preventing fluid overload. CRRT is indicated for patients who cannot tolerate intermittent dialysis due to hemodynamic instability from their critical illness.
This document provides information on inserting tunneled dialysis catheters. It discusses the preferred insertion sites being the right internal jugular vein. Potential acute complications during insertion include arterial puncture, pneumothorax, hemothorax, and air embolism. Subacute complications after insertion include suboptimal flow due to malposition, kinking, clots or fibrin sheath formation. Tunnel tract infection is also discussed as a complication requiring antibiotic treatment and catheter removal. The document provides guidance on preventing and managing these potential complications.
- Short-term catheters should only be used for acute dialysis or limited hospital use. Non-cuffed femoral catheters are only for bed-bound patients.
- Long-term catheters should be used with a plan for permanent access and prefer those capable of high flow rates. Choice depends on local experience and goals.
- Long-term catheters should avoid the same side as a maturing arteriovenous access, if possible.
This document discusses the management of pregnant women on hemodialysis. It notes that physiological changes during pregnancy can impact kidney function, but intensive hemodialysis of more than 20 hours per week is recommended to reduce risks. Close monitoring of blood pressure, nutrition, mineral levels, anemia and fetal growth is important. Hemodialysis prescription should be tailored to each patient's needs, with adjustments to dialysate composition and blood flow. Vaginal delivery at 38 weeks is typically recommended unless complications arise. A multidisciplinary team of nephrologists, obstetricians and dietitians helps optimize outcomes for these high-risk pregnancies.
This document discusses evaluating the adequacy of hemodialysis treatment. It states that numerous studies have shown a correlation between the delivered dose of hemodialysis and patient mortality and morbidity. The urea reduction ratio (URR), which measures the percentage reduction of urea levels pre- and post-dialysis, is one way to evaluate adequacy, with a URR over 60% generally associated with better outcomes. Equilibrated Kt/V is also discussed as a standard measure of dialysis dose, with a minimum of 1.4 recommended. The document outlines factors that influence adequacy, including treatment time and frequency, dialyzer characteristics, blood and dialysate flow rates, and dialysis solution composition
Although large efforts are spent for creating fistula as the primary access, use of Hemodialysis Vascular catheters are still the major access on the first Hemodialysis session and after 4 month whether we would like it or not.
"USRDS 2013"
A very simple yet comprehensive presentation to understand the concept of CRRT and its implementation in Intensive Care Unit. Intended for the very beginners in ICU. After going through the presentation you will be able to say "Now I know it!"
This document discusses guidelines for prescribing hemodialysis for acute kidney injury patients. It covers key elements of the prescription including session length and blood flow rate, dialyzer selection, dialysate composition, and ultrafiltration orders. The presentation emphasizes starting more frequent but shorter sessions at lower intensity initially and gradually increasing session length and clearance as the patient stabilizes to prevent dialysis disequilibrium syndrome.
The document discusses the history and development of hemodialysis adequacy measures. It describes how Frank Gotch and John Sargent developed the Kt/V measure in the 1970s to more accurately assess dialysis dose based on urea clearance. This resolved issues with prior methods that used target BUN levels. The document outlines the benefits of Kt/V over BUN and notes minimum recommended levels of Kt/V and URR to ensure adequate dialysis.
Renal replacement therapies like dialysis and continuous renal replacement therapies are used to replace kidney function in patients with kidney failure. Dialysis involves diffusion of toxins out of the bloodstream across a semipermeable membrane. The main types of dialysis are hemodialysis, which uses an external dialysis machine, and peritoneal dialysis, which uses the patient's peritoneum. Hemodialysis requires vascular access via an arteriovenous fistula or graft and occurs several times per week. Peritoneal dialysis involves infusing dialysate into the peritoneal cavity daily to remove waste through the peritoneum. Continuous renal replacement therapies continuously filter blood using convection and diffusion.
The document discusses complications of peritoneal dialysis, specifically peritonitis. It describes the typical presentation of peritonitis as abdominal pain and cloudy dialysate fluid. Causes include breaks in sterile technique or recent infections. Diagnosis requires abdominal pain and cloudy fluid with leukocytosis. Treatment involves empiric antibiotics targeting gram positive and negative organisms. Outcomes depend on causative organisms and whether the peritoneal catheter is infected.
This document discusses principles of hemodialysis including definitions, concepts of clearance, and factors that affect diffusion and ultrafiltration during the hemodialysis process. It describes how solutes and water move across the semipermeable dialysis membrane through diffusion, osmosis, and ultrafiltration. Key factors that determine solute removal rates and ultrafiltration volumes are membrane type, blood and dialysate flow rates, and transmembrane pressure. The document also compares diffusive and convective solute removal and discusses how countercurrent dialysate flow optimizes solute clearance.
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfAyman Seddik
1. The document discusses guidelines for the prevention and management of peritonitis from the ISPD 2022 updates. It focuses on key areas such as the standardized definitions of peritonitis, measurement of peritonitis rates, prevention strategies like exit site care and antibiotic prophylaxis, and treatment recommendations.
2. The new guidelines recommend monitoring peritonitis rates and aiming for a rate of less than 0.4 episodes per patient year. Prevention strategies discussed include proper exit site care, antibiotic prophylaxis before catheter placement and invasive procedures, and patient education.
3. Treatment guidelines cover initial antibiotic therapy based on peritonitis type and symptoms, and monitoring response and indications for catheter removal. Overall the document summar
This document provides an overview of chronic kidney failure (CKF), including its definition, classification, incidence, etiology, clinical presentation, investigations, management, complications, and references. Some key points include:
CKF is a progressive decrease in renal function over 3 months or more, leading to accumulation of waste and electrolyte abnormalities. Diabetes and hypertension are the leading causes of CKF. Treatment options for CKF include dialysis, renal transplant, or conservative management. Dialysis can be done through hemodialysis or peritoneal dialysis. Renal transplant provides the best outcomes for patients compared to long-term dialysis.
This document provides an overview of chronic kidney disease (CKD) and obstructive uropathy. It defines CKD and obstructive uropathy, discusses the stages of CKD, and outlines the mechanisms by which obstructions can lead to CKD, including both mechanical and non-mechanical obstructions. Specific conditions that can cause obstructions are presented such as posterior urethral valves. Management approaches including surgical and medical treatments are discussed, with an emphasis on long-term monitoring and care to preserve renal function and slow CKD progression.
UTI in kidney transplantation recipients 2017CHAKEN MANIYAN
This patient is a 21-year-old female kidney transplant recipient who presented with dysuria and suprapubic pain. Initial investigations revealed a urinary tract infection with E. coli. She was treated with ciprofloxacin initially but symptoms did not improve. Further workup found hydronephrosis of the transplant kidney and myoma uteri. She was hospitalized and treated with ertapenem intravenously. Repeat investigations showed improvement in symptoms and graft function.
Hypospadias is a congenital anomaly where the urethral opening is on the underside of the penis. It occurs in about 1 in 300 male births and has some genetic factors. Treatment is through surgical urethroplasty to reconstruct the urethra and correct any curvature. Outcomes include some urinary and sexual dysfunction compared to controls, with more issues for proximal versus distal hypospadias. The goal of surgery is a functional penis with normal appearance.
This document provides information about urethral catheters, including who can perform catheterization, the purposes of catheterization, types of catheters, and how to properly insert a catheter. Catheterization can be used to drain the bladder, obtain urine samples, or deliver therapeutic agents to the bladder. Factors like patient age, gender, and medical condition determine the appropriate catheter size and material. Proper sterile technique and use of lubricant are important to prevent trauma and infection when inserting a catheter.
This document provides a case study and overview of prostate artery embolization (PAE) for treating benign prostatic hyperplasia (BPH). It describes a 62-year-old male patient with severe lower urinary tract symptoms whose 140cc prostate made him a non-surgical candidate for traditional procedures. The document outlines the author's training in urology residency, literature research on PAE, and discussions with other physicians. It then details the patient's PAE procedure, follow-up visits showing symptom and prostate size reduction, and lessons learned. Finally, it discusses an upcoming randomized controlled trial to obtain FDA approval for PAE as a treatment for BPH.
This document provides an overview of peritoneal dialysis, including:
1. Peritoneal dialysis removes waste and fluid from the blood through diffusion and ultrafiltration across the peritoneal membrane in the abdomen.
2. The peritoneal membrane contains pores that allow transport of water, small solutes, and macromolecules. Transport is assessed through the peritoneal equilibration test.
3. Prescriptions are tailored based on membrane transport characteristics, with more frequent exchanges for high transporters to optimize fluid removal and clearance of waste.
A 25 year old female presented with a burst abdomen 14 days post-LSCS. Predisposing factors for burst abdomen include wound infection and early stitch removal. Treatment options include immediate re-suture with deep retention sutures and broad spectrum antibiotics to address any infection, leaving the skin open if severe sepsis is present.
Renal cell carcinoma after kidney transplantation 2017CHAKEN MANIYAN
This case discusses a patient who underwent a living related kidney transplant and subsequently developed increased creatinine levels and CMV viremia. Further workup revealed an enhancing nodule in the patient's native right kidney. The patient underwent surgery where a 3x3cm solid mass was removed from the right lower pole of the native kidney. A review of literature on renal cell carcinoma after kidney transplantation showed it can develop through transmission from donor, de novo occurrence in recipient, or recurrence in recipient. Immunosuppression places transplant patients at higher risk for developing various cancers.
The document provides tips for using a PowerPoint presentation on the management of upper gastrointestinal hemorrhage. It recommends that users can freely edit and modify the slides. It also suggests showing blank slides first to elicit what students already know before presenting content on subsequent slides. This active learning approach should be repeated through three revisions for maximum learning. The presentation is also useful for self-study.
ANAESTHESIA AND ANALGESIA IN CLASSIC BLADDER EXSTROPHY REPAIR.pptxDrVANDANA17
This document presents a case report of anaesthetic implications in classic bladder exstrophy repair in a 4-month-old male pediatric patient. Key considerations included long operating times of 5-7 hours, unpredictable bleeding and fluid shifts requiring close monitoring, and providing adequate postoperative pain management. An epidural catheter was carefully placed and intermittent doses of bupivacaine with fentanyl were administered intraoperatively and postoperatively for 3 days to provide excellent pain control while minimizing sedation. The 8-hour surgery was successful and the patient recovered well with normal follow-ups. Epidural analgesia provides safe and effective pain management for such complex pediatric bladder exstrophy repairs when administered carefully.
1. A 47-year-old male presented with abdominal pain, back pain, weight loss, and worsening diabetes. Imaging showed ill-defined masses in the pancreas. Differential considerations included pancreatic malignancy or autoimmune pancreatitis.
2. Endoscopic ultrasound-guided fine needle aspiration of the masses was nondiagnostic but showed no malignancy. Surgery found an infiltrative pancreatic mass but biopsy again showed no malignancy.
3. Follow up showed jaundice and imaging characteristics suggestive of autoimmune pancreatitis. Histopathology and elevated IgG4 supported a diagnosis of type 1 autoimmune pancreatitis. The patient was started
Tapping methodology in modern and ayurvedic therapy arunithar
The document discusses various tapping procedures used in modern and Ayurvedic medicine including paracentesis, thoracentesis, pericardiocentesis, arthrocentesis, lumbar puncture, ventriculoperitoneal shunting, and hydrocele aspiration. It provides indications, contraindications, procedures, and complications for each type of tapping. The document also discusses Ayurvedic concepts and tools related to shastra karma or surgical procedures.
This document presents the case of a 69-year-old male undergoing TURP surgery for benign prostatic hyperplasia. It discusses his medical history of hypertension managed with medications. On examination, he has a METS score of over 4 indicating poor cardiopulmonary reserve. Key considerations for anesthesia include managing blood pressure, maintaining adequate bladder pressure and temperature. Complications of TURP include TURP syndrome, bleeding, and bladder perforation. The anesthetic plan involves careful fluid management and monitoring for early detection of complications.
This document provides information on various pediatric medical instruments and procedures. It describes the indications, contraindications, complications and steps for performing lumbar punctures, bone marrow aspirations, liver biopsies, nasogastric/feeding tubes, suction tubes, scalp vein needles, Ambu bags, bag valve masks, Guedel airways, and laryngoscopes. Key details are provided for each instrument/procedure including appropriate sizes, positioning, sterile technique, and monitoring for complications.
Deep Vein Pathophysiology: Reflux & ObstructionVein Global
By: Peter J. Pappas, M.D.
Visit VeinGlobal at http://www.veinglobal.com/ for more presentations and videos on this topic, or for more information on venous disease news, education and research.
Presentation at the SRMO weekly teaching for Shellharbour Hospital ED - by Dr Mahsa Fateminayyeri, MD - trainee, who covers an approach to sepsis in the ED setting, and highlights the value of a sepsis pathway to expedite antibiotic treatment and provide early resuscitation in order to promote good outcomes
This study compared balanced crystalloids (lactated Ringer's and Plasma-Lyte A) to normal saline in over 15,000 critically ill patients admitted to ICUs at Vanderbilt University Medical Center. The primary outcome was a composite of major adverse kidney events within 30 days. Results showed the absolute risk of the primary outcome was 1.1% lower in patients who received balanced crystalloids compared to saline. Subgroup analyses found greater differences in patients with sepsis and those receiving larger fluid volumes. The authors conclude balanced crystalloids may reduce the risk of new renal replacement therapy, persistent renal dysfunction, or death compared to saline in critically ill adults.
Topic scleroderma and kidney Chaken ManiyanCHAKEN MANIYAN
Systemic sclerosis is a systemic autoimmune disease characterized by abnormal collagen deposition and fibrosis of the skin and internal organs. Scleroderma renal crisis is an uncommon but significant complication of systemic sclerosis that can lead to high mortality. It is defined as new onset hypertension accompanied by renal failure and microangiopathic hemolytic anemia. Early diagnosis and treatment with angiotensin-converting enzyme inhibitors has been shown to improve survival outcomes for patients with scleroderma renal crisis.
Acute Allograft rejection in kidney transplantation 2017 ChakenCHAKEN MANIYAN
This document discusses transplant immunology and the immune response after kidney transplantation. It provides details on the innate and adaptive immune system, acute T cell mediated rejection and antibody mediated rejection, and the updated 2015 Banff classification system. The summary describes:
1. The innate and adaptive immune system work together to identify and remove foreign substances from the body. The adaptive system has antigen recognition and memory capabilities.
2. Acute rejections can be T cell mediated or antibody mediated. T cell mediated rejection involves T cell infiltration and tubulitis, while antibody mediated rejection is caused by donor-specific antibodies binding to the graft.
3. The 2015 Banff classification system categorizes rejection and provides standardized grading scales for inflammation
Cardiorenal syndrome describes conditions where acute or chronic dysfunction in the heart leads to acute or chronic kidney disease, and vice versa. There are five subtypes classified based on temporal presentation and direction of organ dysfunction. Ultrafiltration is a treatment for fluid overload in heart failure that works by removing excess fluid without changing electrolyte levels. Several studies have found ultrafiltration improves congestion symptoms and reduces rehospitalization rates compared to intravenous diuretics alone. Larger and longer term studies are still needed to establish optimal use of ultrafiltration in cardiorenal syndrome.
Intensive blood pressure control aimed at a systolic blood pressure under 120 mm Hg was associated with a small increased risk of developing chronic kidney disease over 3 years compared to standard blood pressure control between 135-139 mm Hg. However, the intensive control group had a lower risk of cardiovascular events and death, outweighing the kidney disease risk. While some patients in the intensive group saw acute drops in kidney function, long term outcomes were unclear and many recovered function. The study suggests the benefits of intensive blood pressure control likely outweigh the risks, but some patients may weigh kidney disease risk more heavily than cardiovascular outcomes.
Journal club multitarget therapy lupus nephritis maintenance chaken CHAKEN MANIYAN
Multitarget therapy of tacrolimus, mycophenolate mofetil and steroids achieved a 45.9% complete remission rate in induction treatment of lupus nephritis. This study assessed the efficacy of continuing multitarget therapy versus switching to azathioprine as maintenance treatment over 18 months. The cumulative renal relapse rate was lower in the multitarget group at 5.47% compared to 7.62% in the azathioprine group. More patients in the multitarget group maintained complete remission during maintenance treatment with no significant differences in safety profiles between the groups.
Vascular access in hemodialysis chaken 2018CHAKEN MANIYAN
This document provides guidelines and information about vascular access for hemodialysis. It discusses:
- Types of vascular access including arteriovenous fistulas, grafts, and catheters. Fistulas have the lowest risk of complications but the highest risk of early failure.
- Evaluations for permanent access including history, physical exam, ultrasound of arteries and veins, and central vein evaluation.
- Placement of fistulas at least 6 months before starting dialysis to allow for maturation. Grafts can be placed 3-6 weeks before starting.
- Goals for types of access used - 50% of patients should have fistulas, 40% grafts, and no more than 10%
This document provides information on membranoproliferative glomerulonephritis (MPGN), including its classification, pathogenesis, clinical presentation, pathology, and treatment. MPGN is classified based on immunofluorescence and electron microscopy findings. It can be immune-mediated via immune complex deposition or complement-mediated via dysregulation of the alternative complement pathway. On pathology, it is characterized by thickened glomerular basement membranes, mesangial hypercellularity, and endocapillary proliferation. Clinical presentation varies from asymptomatic to nephrotic syndrome or renal failure.
Journal club NEJM kidney transplantation IDES 2017CHAKEN MANIYAN
1) IdeS is a recombinant enzyme that cleaves IgG antibodies. The study assessed IdeS's efficacy in eliminating donor-specific HLA antibodies (DSAs) in highly sensitized patients undergoing kidney transplantation.
2) After IdeS treatment, IgG and DSA levels were significantly reduced, allowing successful transplantation in 24 of 25 patients. Graft survival and function were good.
3) While IdeS reduced rejection risk, 10 patients still experienced antibody-mediated rejection, which responded well to treatment. One patient had unexpected hyperacute rejection from non-HLA antibodies.
This document discusses infection following renal transplantation. It covers four main categories of exposures that can lead to post-transplant infection: donor-derived, recipient-derived, nosocomial, and community. It then discusses the timeline of various infections, highlighting that CMV and opportunistic infections are most common in the first 6 months. BK virus is also reviewed in depth, including its virology, risk factors for BK virus nephropathy, diagnosis, clinical management and treatment through immunosuppression modification. Cytomegalovirus infection is also summarized, covering terminology, risk factors, diagnostic methods including histopathology, viral culture, serology and molecular assays to detect viral load.
This document provides an overview and outline of topics related to kidney transplantation outcomes and complications. It discusses:
- Short and long-term outcomes of kidney transplantation, including factors that affect allograft survival such as donor and recipient characteristics.
- Common complications that kidney transplant recipients face, including post-transplant diabetes mellitus, hypertension, dyslipidemia, and bone disease.
- Guidelines for screening, diagnosing, and managing these complications through lifestyle modifications and medication adjustments.
- National data on kidney transplantation trends, outcomes, and challenges in improving long-term allograft survival.
Basic science apol1 gene and nephrocyte chakenCHAKEN MANIYAN
This study generated transgenic Drosophila lines expressing human APOL1-G0 and APOL1-G1 alleles. Ubiquitous expression caused developmental lethality. When expressed specifically in nephrocytes (analogous to human podocytes and proximal tubules), APOL1 initially increased nephrocyte endocytosis and size but over time impaired organelle acidification and accelerated cell death. As flies aged, nephrocytes expressing APOL1-G1 in particular became much larger and fewer in number, with accumulation of cell debris. This Drosophila model provides insights into how APOL1 overexpression causes cytotoxicity and progressive nephrocyte dysfunction.
Advanced in hemodialysis and biocompatbility chaken pmkCHAKEN MANIYAN
This document discusses advanced hemodialysis technologies and their role in improving outcomes for hemodialysis patients. It begins by outlining several challenges with hemodialysis including high mortality rates from cardiovascular causes and insufficient removal of toxins like phosphate, middle molecules, and protein-bound solutes. It then describes several modalities for advanced hemodialysis like super high flux membranes, hemodiafiltration, and adsorptive therapies that aim to remove more toxins. The document reviews landmark trials on high flux membranes and discusses how newer technologies may provide benefits like improved clearance of beta-2 microglobulin and phosphate.
Major Chaken Maniyan provides an outline on heat regulation physiology, classifications of heat-related injuries, cooling methods, management of complications, and new interventions. The document discusses heat transfer mechanisms, signs and symptoms of heat-related illnesses ranging from mild to severe including heat rash, heat edema, heat syncope, heat cramps, heat exhaustion, and heat stroke. Cooling techniques like ice water immersion and evaporative cooling are presented, as well as treatments for complications of heat stroke such as renal failure, rhabdomyolysis, and electrolyte abnormalities. Risk factors, pathogenesis, and organ dysfunction in heat stroke are also reviewed.
Induction treatment in Kidney transplantation chaken 2017 CHAKEN MANIYAN
The document discusses various induction immunosuppression agents used after kidney transplantation. It defines induction therapy as treatment given before or at transplantation to deplete or modulate T-cell responses. The major agents covered are depleting antibodies like thymoglobulin, alemtuzumab, and OKT3, and non-depleting antibodies like basiliximab and daclizumab. Clinical trials generally find depleting agents reduce acute rejection rates but increase infection risks, while non-depleting agents have fewer side effects but may have higher rejection rates. Guidelines recommend considering risks and benefits for each patient's situation.
Journal club harmony trial chaken maniyan 2016CHAKEN MANIYAN
This randomized controlled trial compared rabbit antithymocyte globulin (ATG) induction versus basiliximab induction for allowing rapid steroid withdrawal in renal transplant recipients on tacrolimus and mycophenolate mofetil immunosuppression. The primary outcome was biopsy-proven acute rejection rates within 1 year, and secondary outcomes included patient and graft survival, post-transplant diabetes, and cardiovascular risk factors. Results showed that rabbit ATG was not superior to basiliximab in preventing acute rejection. However, rapid steroid withdrawal significantly reduced post-transplant diabetes rates without compromising efficacy or safety.
This document provides guidance on evaluating and screening potential renal transplant recipients. It discusses:
1. General concepts to consider include referring all end-stage renal disease patients for transplant evaluation once renal replacement therapy is needed within 12 months, and encouraging preemptive kidney transplantation when feasible.
2. The evaluation process involves assessing medical history and conditions, performing initial screening tests, and evaluating any cardiovascular, infectious, or other systemic diseases to identify any absolute contraindications to transplantation or conditions requiring further treatment and monitoring.
3. Cardiovascular disease is a major cause of death for transplant recipients, so candidates undergo cardiac screening and testing based on risk factors to clear them for surgery or identify any need for pre-operative cardiac
This document discusses post-transplant renal artery stenosis (TRAS). TRAS occurs in 1-23% of kidney transplant recipients, usually within the first 2 years after transplantation. Risk factors include technical errors during surgery, atherosclerosis, and immunosuppression. Clinical manifestations include worsening hypertension and graft dysfunction. Diagnosis involves renal duplex ultrasound showing elevated peak systolic velocities. Treatment options are medical management with ACE inhibitors for mild cases, percutaneous transluminal angioplasty with stenting for significant stenosis, or surgical revascularization for failed angioplasty. Angioplasty with drug-eluting stents has lower restenosis rates compared to angioplasty alone.
1) Several novel urinary biomarkers such as KIM-1, NGAL, and LFABP have been shown to be early predictors of acute kidney injury (AKI), rising in the urine within hours of injury compared to the rise in serum creatinine which occurs later.
2) Biomarkers like NGAL and KIM-1 have been shown to predict progression of AKI severity and long-term outcomes like need for renal replacement therapy and mortality.
3) Studies have demonstrated the utility of biomarkers like plasma NGAL measured at the time of clinical diagnosis of AKI after cardiac surgery to predict AKI severity and risk stratify patients for worse outcomes.
This document discusses the pathophysiology of acute kidney injury (AKI). It covers pre-renal, post-renal and intrinsic renal AKI. For intrinsic renal AKI, it focuses on acute tubular necrosis (ATN). It describes the hemodynamic changes, endothelial dysfunction, inflammatory response and tubular injury that occur in ATN. Hemodynamic changes like renal hypoperfusion can cause ischemia. This results in endothelial activation, leukocyte recruitment and coagulation changes. Tubular injury involves loss of polarity, cytoskeleton disruption and cell death via necrosis or apoptosis. The document provides details on the molecular mechanisms and pathways involved in each step of the pathophysiological process of ATN.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
3. Case Presentation
§ESRD initiated CAPD since March 2016 (TK insertion since Feb 2016)
§ Initial PD prescription: 1.5 % PD fluid 2 L x 4 cycle/d
dwell time 4 hr/cycle
§ Average UF 200-400 ml/d
§ Residual urine 600-700 ml/d
§Hypertension
§Dyslipidemia
§Gout
§Primary hyperthyroidism
§Vitamin D deficiency
6. Personal history
§Personal history
§ ปฏิเสธยาลูกกลอน/ยาสมุนไพร/ยาต้ม/ยาชุด
§ ปฏิเสธดื่มสุรา สูบบุหรี่
§ ไม่มีสัตว์เลี้ยงที่บ้าน
§ Family history :
§ ปฏิเสธโรคไตในครอบครัว
7. Current medication
§ Losartan(50) 1x2 o pc
§ Hydralazine (25) 2x4 o pc
§ Metroprolol (100) ½ x1 o pc
§ Furosemide (500) 1x1 o pc เช ้า
§ Aldactone (25) 2x1 o pc
§ Amlodipine(10) 1x1 o pc
§ Ferrous fumarate (200) 1x3 o ac
§ Simvastatin (10) 1 x1 o hs
§ PTU (50) 1x1 o pc
§ CaCO3(1) 1x2 with meal
§ Vitamin D2 (20,000) 1cap o จันทร์ พฤหัส
§ KCl elixir 15 ml o OD
§ Pregabalin (25) 1x1 o hs
8. Physical examination
§ V/S: BT 36.6 C, RR 22 /min, BP 151/61 mmHg, HR 110 /min BW 66 kg
§GA:An elderly Thai female, alert , follow to command
§HEENT: mildly pale conjunctivae, anicteric sclera, no thyroid gland enlargement
§LN: not palpable
§CVS: JVP 4 cm above sternal angle , normal S1 S2, no murmur
§Lungs: Trachea in midline , Normal chest contour , dullness on percussion over
left lung , decreased breath sound left lower lung, no wheezing
§Abdomen: mild distension, active bowel sound, soft, not tender, no guarding,TK
insertion no erythema, no purulent discharge, not tender along tunnel route
§Extremities : No pitting edema
§ Neuro : good consciousness , follow to command, no facial palsy
§ No weakness , decrease pinprick sensation both lower legs , BBK plantar
flexion
9. Problem lists
§Progressive dyspnea in ESRD on CAPD patient
§Possible Left pleural effusion
§Hypertension
§Dyslipidemia
§Gout
§Primary hyperthyroidism
§Vitamin D deficiency
15. What is the further investigation
and RRT management in this case
16. Initial management
§ 1.5 % PDF 1500 ml, dwell time 3 hour for 3 cycle
§ 4.25 % PDF 1500 ml, dwell time 4 hour last cycle
§ Dry abdomen in nighttime
§ Increase furosemide to 1 gm /d
§ Advice patient to dialysis in upright position
20. Follow up April 2017
§ มา F/U มีปัญหา PD ขาดทุนตลอด วันละ 1500-2000 ml
ตลอด ปัสสาวะออกวันละ 500-600 ml ต่อวัน
§มีอาการบวม หอบเหนื7อยมากขึGน +orthopnea , + PND
§ไม่มีไข ้ไม่มีท ้องผูก ถ่ายอุจจาระได ้ทุกวัน
21. Physical examination
§ V/S: BT 36.6 C, RR 22 /min, BP 190/100 mmHg, HR 92 /min BW 69 kg
§GA:An elderly Thai woman, follow to command
§HEENT: mildly pale conjunctivae, anicteric sclera, no thyroid gland enlargement
§LN: not palpable
§CVS: JVP 4 cm above sternal angle , normal S1 S2, no murmur
§Lungs: Trachea in midline , Normal chest contour , equal breath sound
§Abdomen: mild distension, active bowel sound, soft, not tender, no guarding,TK
insertion no erythema, no purulent discharge, not tender along tunnel route
§Extremities : pitting edema 2+
§ Neuro : good consciousness , follow to command, no facial palsy
§ No weakness , decrease pinprick sensation both lower legs , BBK plantar
flexion
27. Requirement of catheter for dialysis adequacy
§Peritoneal membrane w/o sclerosis/adhesions
§Abdominal wall w/o leaks or hernias
§Subcutaneous tract w/o infection
§Skin exit site w/o infection
§Catheter surface w/o persistent biofilm
5th edition Handbook of Dialysis
28. Why Is Design or Surgical Technique Important?
§ Reduce risk for catheter-related complications
Mechanical Complications
Inadequate Hydraulic Function
Omental Entrapment
Leaks
Infectious Complications
Exit-Site
Tunnel
Peritonitis
5th edition Handbook of Dialysis
29. Catheter Material
§ Catheters are made either of polyurethane or silicone
§ Either mupirocin or gentamicin - damage polyurethane
§ Manifestations of Damage:
§Opacification of catheter
§Leaks – leading to peritonitis
§Rarely – rupture of catheter
5th edition Handbook of Dialysis
30. Common used catheter set:
Double cuff, swan neck, coiled Tenckhoff design.
avoid cuff extrusions.
5-mm external diameter and
internal diameters of 2.6 -3.5 mm.
Decreases pain during PD and less likely to migrate.
Nebel M, et al .Adv Perit Dial 7:208–213, 1991
Prevent infection (ESI,Tunnel infection, peritonitis)
31. Internal diameters for PD catheters
(outer diameter of 5 mm )
Flex-Neck Tenckhoff catheter (silicone)
Internal diameter 3.5 mm
Cruz Tenckhoff catheter (polyurethane)
Internal diameter 3.1 mm
standard Tenckhoff (silicone)
Internal diameter 2.6 mm
T-fluted catheter (Ash Advantage, silicone)
Adapted from Crabtree J. Kidney Int Suppl 2006; 70: S27-37
32. Proper position of peritoneal cuffs
External Segment
Tunneled Segment
Intra-Peritoneal Segment
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
33. Intraperitoneal portion
1. Straight Tenckhoff, 8-cm ,1-mm side holes
2. CurledTenckhoff, 16-cm, 1-mm side holes
3. Straight Tenckhoff/ perpendicular silicone
discs (Toronto-Western)
4. T-fluted catheter (Ash Advantage), aT-
shaped catheter with grooved limbs
positioned against the parietal peritoneum
1 2
3
4
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
34. Superiority of intraperitoneal catheter design
§No consistent data to support
§2014 meta-analysis : straight segments compare with
coiled
§remain functional at 2 years (79 /55 %)
§faster failure (1.4/2.1 yrs) (inadequate small-solute
clearance
§lower rate of late catheter tip migration (5VS 32 %)
Hagen SM, et al . Kidney Int 2014; 85:920.
Johnson et al,Am J Kidney Dis, 2006
35.
36. Subcutaneous portion
§1-2 extraperitoneal Dacron
(made from polyester)
§Induce fibrous plug
§fix catheter in position
§prevent fluid leaks
§prevent bacterial migration
§Similar rates of ESI, peritonitis,
migration, leakage, removal, and
dysfunction
42. Probability of Free of Mechanical Flow Obstruction
At 24 Months Increased by Newer Techniques
Crabtree JH et al .Am Surg . 2005 ; 71:135-143
43. Proper position of Catheter
§Intraperitoneal portion - between visceral and parietal
peritoneum, near pouch of Douglas (cal de sac)
§ Hydraulic function of catheter AND
§ Minimize omental entrapment
§Inner cuff should be inserted in rectus muscle to prevent
leaks.
§Outer cuff - subcutaneous tissue (create a dead space in
between cuffs) approximate 2 cm
§Subcutaneous tract and exit site should face downward and
laterally to avoid exit site infection.
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
44. Location of deep cuff
Placingde ep cuff in abdominal musculature
- promotes tissue ingrowth
- minimizes pericatheter hernias, leaks
- catheter extrusion, and exit site erosion
45. Principle of exit site placement
§Away from belt-lines, skin creases, and folds
§Clearly visible to daily exit site care
§About one inch from the superficial cuff
46. Selection of various catheter
Belt line below umbilicus à swan-neck catheter preferred
if lateral point , a straight catheter is preferable
Selected patients prefer uppper or presternal tips
Crabtree J. Kidney Int Suppl 2006; 70: S27-37
47. Presternal Exit-Site is Easily Visualized and
Remote from Urostomy
Guest S. Handbook of Peritoneal Dialysis, 2011
48. Indication for presternal catheter
§ Morbid obesity
§ Floppy abdominal skin folds
§ Presence of stoma(colostomy, ileostomy, or urostomy)
§ Incontinence of urine or feces
§Very young children who wear diapers
§ Patients with Hx of recurrent catheter infections
Guest S. Handbook of Peritoneal Dialysis, 2011
49. Postoperative catheter care
§Covered with a nonocclusive dressing and should not be
used for 10-14 days.
§Catheter should be flushed at least 1-2 times /wk with
saline or dialysate solution
§Low-volume PD may be attempted within 24 hours in case
of emergency
Song JH, Kim GA, Lee SW, et al:. Perit Dial Int 2:194–199, 2000
50. ISPD : Implantation protocol
§Preoperative:
§ Check for hernias/ MRSA and nasal carriage of S. aureus;
§ Suitable catheter length
§ Marking exit site with the patient sitting or standing. •
§ Preparing bowel with laxatives; ensuring bladder emptying;
administering prophylactic antibiotics
§ Post-procedure: flushing catheter and cap off using suitable dialysate
§ Covering exit site w/ dressing and, if possible, not disturbing for 5 –
10 days;
§ Immobilizing the catheter
§ Choice of antibiotic should be based upon local guidelines, with
consideration given to efficacy, risks of selection of resistant
organisms, and development of Clostridium difficile colitis
ISPD CLINICAL PRACTICE GUIDELINES FOR PERITONEAL ACCESS , Peritoneal Dialysis International,Vol. 30, pp. 424–429, 2010
51. Audit standards for catheter-related complications:
§Bowel perforation: < 1%
§Significant hemorrhage: < 1%
§Exit-site infection in 2 weeks of insertion: < 5%
§Peritonitis within 2 weeks of insertion: < 5%
§Functional catheter problem requiring manipulation or
replacement or leading to technique failure: < 20%
§At least every 12 months, a combined meeting between
surgeons (or other healthcare providers inserting PD
catheters) and the nephrology team should be held to
review PD catheter data
ISPD CLINICAL PRACTICE GUIDELINES FOR PERITONEAL ACCESS , Peritoneal Dialysis International,Vol. 30, pp. 424–429, 2010
53. Early pericatheter leak
§3 factors :
§ catheter implantation technique
§ timing of initiation
§ strength of abdominal wall tissues.
§Confirmed by glucose dipstick indicating high glucose
§Discontinue for 1–3 weeks usually spontaneous cessation
§Leakage through exit site tunnel :: ↑ risk infection
54. Late pericatheter leaks
§Caused by pericannular hernia or occult tunnel
infections, (with separation of the cuffs)
§If abdominal wall is weak : track may dilate , develop true
hernia.
§Most late leaks and pericatheter hernias are best managed
by catheter replacement.
55. Pericatheter leakage
§Treatment
§Reduce physical activity
§Reduce dialysate volumes
§Conversion to cycler
§Temporary conversion to HD
§If conservative measures fails then surgical repair of deep
cuff or catheter replacement
56. Infusion pain
§ Usually resolved in several weeks in new patients
§ Persistent pain
§ Acidity (pH 5.2–5.5) of conventional lactate based dialysate
§ Use of bicarbonate/lactate- buffered dialysate (pH 7.0–7.4)
§ 1% or 2% lidocaine solution added to the dialysate (5 mL/L)
§Other causes
§ hypertonic dialysate
§ aged dialysate
§ overdistended abdomen
§ extreme temperature
§ straight-tip cathters (jet effect).
§ catheter malposition with tip against abdominal wall
57. Drain pain
§Common in early days after initiation of dialysis.
§Tip of catheter against sensitive parietal peritoneum
§ Constipation (bowel around catheter in pelvis)
§ More frequently in APD due to hydraulic suction
§ If persistent pain à avoid complete drainage of effluent
58. Outflow failure
§Definition: Incomplete recovery of instilled
dialysate
§Incidence: 5-20%
§Etiologies
§Constipation (anytime)
§Catheter malposition (days)
§Intraluminal catheter occlusion by thrombus
§Extraluminal catheter occlusion by omentum or
adhesions (weeks)
§Kinking (soon after placement, positional)
§Loss of dialysate from peritoneal cavity
59. Diagnosis
§History
§ Flow disturbance – inflow, outflow or both
§ When was the catheter placed
§ Constipation
§ Pain
§ Dyspnea
§ Fibrin in dialysate drain
§Plain film
§ Severe constipation
§ Catheter malposition
§Lost dialysate: pericatheter dialysate leakage; either internal
or external
60. Treatment
§Constipation
§More than half of the cases are cured with releif of
constipation
§Laxatives, stool softeners, suppositories or enema
§Fibrin clot
§Heparin 500-1000 units/L of dialysate for lysis
§Urokinase – instilled in catheter for 1 hour and then
removed
§Recombinant tPA – used if obstruction is refractory
61. Treatment
§Malpositioned catheter
§Fluoroscopy with stiff wire manipulation
§Redirection either laproscopically or surgically
§Replace catheter if not successful
§Catheter kinking
§Usually requires catheter replacement
§Abdominal exploration may be necessary for catheter
redirection, omentectomy or adhesiolysis or catheter
replacement
62.
63. Catheter cuff extrusion
§Catheter cuff erodes through the skin to the outer
abdominal wall
§Can be 2nd from ESI or superficial cuff placement
§Incidence: 3.5 – 7%; no specific association with
catheter type and method of placement
§Treatment: depends on presence or absence of
infection
§ No infection: extruding cuff removed by opening the
subcutaneous tissue at exit site and trimming the cuff under
sterile conditions
§ Infection present: remove the catheter
64. Pleural effusion associated peritoneal dialysis
§Possible etiologies:
§Volume overload, CHF
§Local pleural process
§Peritoneal dialysate (pleuroperitoneal fistula)
§Suspicion of peritoneal dialysate in a non-edematous pt
with inadequate UF
§Incidence: 1.6%, more common in females
§ADPKD patients prone to have due to decreased
abdominal capacity
5th edition Handbook of Dialysis
65. Pleural effusion
§Usually occurs early after starting PD
§Unrelated to dialysate volumes
§Hypotheses:
§Congenital communication between pleura and
peritoneum. Dissection of fluid through defects around
major vessels and the esophagus
§Combination of increased intra-abdominal pressure and
negative intra-thoracic pressure may open small defects in
the diaphragm
5th edition Handbook of Dialysis
66. Pleural effusion
§Clinical features
§Can be asymptomatic
§Dyspnea on exertion
§Inadequate UF
§More common on right side
§Occurs early after PD initiation, 50% of cases within 1st
month
§Diagnosis: glucose level higher than serum (no cut point)
§ Nuclear scintigraphy is the most reliable test
5th edition Handbook of Dialysis
67. Pleural effusion
§Treatment: depends on acuity and severity
§Thoracentesis
§Drain peritoneal cavity and avoid overnight supine dwells
§If recurrent and unresponsive: chemical pleurodesis using
talc, tetracycline
§Surgical correction if diaphragmatic defect is identified
§Temporary conversion to HD
5th edition Handbook of Dialysis
72. EPS: Diagnosis
§Markers of inflammation
§Elevated CRP
§Anemia, resistant to ESA’s
§Hypoalbuminemia
§Radiology: CT scan
§Peritoneal thickening
§Peritoneal calcification
§Tethering and cocooning of bowel
§Small or large bowel obstruction
74. CT Findings of EPS
Cameron et al:American Roentgen Ray Society Annual Meeting, 2010
75. CT Findings of EPS
Cameron et al:American Roentgen Ray Society Annual Meeting, 2010
76. EPS: Treatment
§Corticosteroids:
§ Useful in inflammatory phase
§ Both pulse steroids or daily therapy can be used
§ Reported 38.5% remission rate with corticosteroids
§Tamoxifen: case reports
§Surgical treatment
§ Surgical lysis of intestinal adhesions and stripping of fibrous cocoon
§ Indications for surgery:
§ recurrent bowel obstruction
§ worsening nutritional status
§ failure medication
Mario R. , et al Nature Reviews Nephrology 7, 528-538 (September 2011)